Barbara Claus

1.0k total citations
25 papers, 495 citations indexed

About

Barbara Claus is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Geriatrics and Gerontology. According to data from OpenAlex, Barbara Claus has authored 25 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 9 papers in Economics and Econometrics and 6 papers in Geriatrics and Gerontology. Recurrent topics in Barbara Claus's work include Pharmaceutical studies and practices (9 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Barbara Claus is often cited by papers focused on Pharmaceutical studies and practices (9 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Barbara Claus collaborates with scholars based in Belgium, Netherlands and Germany. Barbara Claus's co-authors include Hugo Robays, Johan Decruyenaere, Kirsten Colpaert, Jan J. De Waele, Eric A. J. Hoste, Annemie Somers, Koenraad Vandewoude, Tiene Bauters, Steven Simoens and Lieven Annemans and has published in prestigious journals such as Critical Care Medicine, Journal of Antimicrobial Chemotherapy and Critical Care.

In The Last Decade

Barbara Claus

24 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Claus Belgium 10 150 128 116 96 79 25 495
Hugo Robays Belgium 19 342 2.3× 290 2.3× 154 1.3× 203 2.1× 81 1.0× 57 1.1k
James C. Garrelts United States 14 207 1.4× 120 0.9× 99 0.9× 124 1.3× 38 0.5× 28 579
K. Bruce Bayley United States 12 93 0.6× 57 0.4× 66 0.6× 171 1.8× 57 0.7× 15 647
Winnie Seto Canada 13 110 0.7× 94 0.7× 158 1.4× 114 1.2× 17 0.2× 36 561
Darryl S. Rich United States 10 92 0.6× 120 0.9× 100 0.9× 32 0.3× 23 0.3× 36 464
W. Lawson United Kingdom 15 104 0.7× 74 0.6× 25 0.2× 122 1.3× 30 0.4× 23 673
Andrew Steele United States 14 22 0.1× 47 0.4× 100 0.9× 71 0.7× 68 0.9× 24 566
Michael Cimino United States 9 138 0.9× 102 0.8× 126 1.1× 57 0.6× 38 0.5× 15 485
Mitchell J. Daley United States 13 94 0.6× 83 0.6× 67 0.6× 188 2.0× 6 0.1× 33 560
Richard S Slavik Canada 14 43 0.3× 105 0.8× 51 0.4× 71 0.7× 17 0.2× 31 531

Countries citing papers authored by Barbara Claus

Since Specialization
Citations

This map shows the geographic impact of Barbara Claus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Claus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Claus more than expected).

Fields of papers citing papers by Barbara Claus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Claus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Claus. The network helps show where Barbara Claus may publish in the future.

Co-authorship network of co-authors of Barbara Claus

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Claus. A scholar is included among the top collaborators of Barbara Claus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Claus. Barbara Claus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claus, Barbara, Delphine De Smedt, & Pieter De Cock. (2025). Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost–benefit analysis. Journal of Antimicrobial Chemotherapy. 80(3). 857–867.
2.
Claus, Barbara, Johannes Förster, Max Petzold, et al.. (2024). The EC-COMPASS: Long-term, multi-centre surveillance of Enterobacter cloacae complex – a clinical perspective. Journal of Hospital Infection. 148. 11–19. 3 indexed citations
3.
Buyle, Franky, Barbara Claus, Annemie Somers, et al.. (2021). Vancomycin dosing and therapeutic drug monitoring practices: guidelines versus real-life. International Journal of Clinical Pharmacy. 43(5). 1394–1403. 24 indexed citations
4.
Claus, Barbara. (2018). Is pharmacovigilance of biologicals cost-effective?. International Journal of Clinical Pharmacy. 40(4). 787–789. 2 indexed citations
5.
Claus, Barbara, Tiene Bauters, & Geneviève Laureys. (2018). Drug shortages in a pediatric stem cell transplantation ward: Challenges and implications. A 5-year bilan. Journal of Oncology Pharmacy Practice. 25(4). 841–846. 2 indexed citations
6.
Gelder, Teun van, et al.. (2017). Pharmacovigilance, traceability and building trust in biosimilar medicines. Generics and Biosimilars Initiative Journal. 6(3). 135–140. 1 indexed citations
7.
Somers, Annemie, et al.. (2016). Experience with the Implementation of Clinical Pharmacy Services and Processes in a University Hospital in Belgium. Drugs & Aging. 33(3). 189–197. 8 indexed citations
8.
Claus, Barbara, Kirsten Colpaert, Kristof Steurbaut, et al.. (2015). Role of an electronic antimicrobial alert system in intensive care in dosing errors and pharmacist workload. International Journal of Clinical Pharmacy. 37(2). 387–394. 9 indexed citations
9.
Claus, Barbara, Sylvia Snauwaert, Filomeen Haerynck, et al.. (2015). Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients. International Journal of Clinical Pharmacy. 37(4). 555–558. 9 indexed citations
10.
Bauters, Tiene, Barbara Claus, Koen Norga, et al.. (2015). Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium. Journal of Oncology Pharmacy Practice. 22(6). 766–770. 19 indexed citations
11.
Claus, Barbara, et al.. (2015). Onbeschikbaarheid van geneesmiddelen in het ziekenhuis: beheer, oorzaken en budgetimpact. Ghent University Academic Bibliography (Ghent University). 95(1). 24–34. 1 indexed citations
12.
Claus, Barbara, Hugo Robays, Johan Decruyenaere, & Lieven Annemans. (2014). Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before‐and‐after groups. Journal of Evaluation in Clinical Practice. 20(6). 1172–1179. 22 indexed citations
13.
Claus, Barbara, Eric A. J. Hoste, Kirsten Colpaert, et al.. (2013). Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. Journal of Critical Care. 28(5). 695–700. 163 indexed citations
14.
Bauters, Tiene, et al.. (2012). What’s in a drop? Optimizing strategies for administration of drugs in pediatrics. International Journal of Clinical Pharmacy. 34(5). 679–681. 9 indexed citations
15.
Claus, Barbara, et al.. (2012). Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital. International Journal of Clinical Pharmacy. 34(5). 773–778. 9 indexed citations
16.
Bauters, Tiene, Barbara Claus, Petra Schelstraete, et al.. (2011). Vancomycin-induced red man syndrome in pediatric oncology: still an issue?. International Journal of Clinical Pharmacy. 34(1). 13–16. 7 indexed citations
17.
Claus, Barbara, Kirsten Colpaert, Eric A. J. Hoste, Johan Decruyenaere, & Jan J. De Waele. (2010). Increased glomerular filtration in the critically ill patient receiving anti-infective treatment. Critical Care. 14(Suppl 1). P509–P509. 5 indexed citations
18.
Vandijck, Dominique, Sandra Oeyen, Franky Buyle, et al.. (2008). Hyperglycaemia upon Onset of Icu-Acquired Bloodstream Infection is Associated with Adverse Outcome in a Mixed Icu Population. Anaesthesia and Intensive Care. 36(1). 25–29. 10 indexed citations
19.
Colpaert, Kirsten, Barbara Claus, Annemie Somers, et al.. (2006). Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial. Critical Care. 10(1). R21–R21. 134 indexed citations
20.
Colpaert, Kirsten, et al.. (2004). MEDICATION ERRORS IN AN ADULT INTENSIVE CARE UNIT: COMPARISON BETWEEN PAPER-BASED AND COMPUTERIZED PHYSICIAN ORDER ENTRY. Critical Care Medicine. 32(Supplement). A96–A96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugo Robays Breakdown of academic impact, for papers by James C. Garrelts Breakdown of academic impact, for papers by K. Bruce Bayley Breakdown of academic impact, for papers by Winnie Seto Breakdown of academic impact, for papers by Darryl S. Rich Breakdown of academic impact, for papers by W. Lawson Breakdown of academic impact, for papers by Andrew Steele Breakdown of academic impact, for papers by Michael Cimino Breakdown of academic impact, for papers by Mitchell J. Daley Breakdown of academic impact, for papers by Richard S Slavik
Rankless by CCL
2026